Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学ROS1 Fusion Resistance Mechanisms

Christine Lovly

MD, PhD

🏢Vanderbilt-Ingram Cancer Center🌐USA

Professor of Medicine

55
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Christine Lovly is a physician-scientist whose laboratory research focuses on kinase-driven resistance in ROS1 and ALK-positive lung cancers. She has characterized on-target and bypass resistance mechanisms to ROS1 inhibitors at the molecular level. Her work has directly informed clinical development of next-generation targeted agents.

Share:

🧪Research Fields 研究领域

ROS1 fusions
Kinase signaling
Drug resistance biology
NSCLC genomics
Translational research

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Christine Lovly 的研究动态

Follow Christine Lovly's research updates

留下邮箱,当我们发布与 Christine Lovly(Vanderbilt-Ingram Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment